Patient Square Capital LP
All holdings · as of Dec 31, 2025
| Company | Value ↓ | % of portfolio |
|---|---|---|
| Roivant Sciences Ltd. | $177.20M | 37.9% |
| INSMED INC | $46.47M | 9.9% |
| Mirum Pharmaceuticals, Inc. | $23.59M | 5.1% |
| ARGENX SE | $21.86M | 4.7% |
| BeOne Medicines Ltd.ONC | $21.06M | 4.5% |
| ABIVAX SA | $17.53M | 3.8% |
| Pharvaris N.V. | $15.06M | 3.2% |
| EyePoint, Inc. | $14.25M | 3.1% |
| Terns Pharmaceuticals, Inc. | $12.93M | 2.8% |
| Celcuity Inc.CELC | $11.97M | 2.6% |
| Cogent Biosciences, Inc. | $11.27M | 2.4% |
| Kymera Therapeutics, Inc. | $10.82M | 2.3% |
| Liquidia CorpLQDA | $7.83M | 1.7% |
| DBV TECHNOLOGIES S.A.DBVT | $6.88M | 1.5% |
| Allogene Therapeutics, Inc. | $6.80M | 1.5% |
| Dianthus Therapeutics, Inc. | $6.18M | 1.3% |
| Xenon Pharmaceuticals Inc. | $6.12M | 1.3% |
| Arcutis Biotherapeutics, Inc. | $6.10M | 1.3% |
| Ocular Therapeutix, Inc | $5.95M | 1.3% |
| Disc Medicine, Inc.IRON | $5.88M | 1.3% |
| Avalo Therapeutics, Inc. | $5.67M | 1.2% |
| SPYRE THERAPEUTICS, INC. | $4.91M | 1.1% |
| Enliven Therapeutics, Inc.ELVN | $4.75M | 1.0% |
| ASSEMBLY BIOSCIENCES, INC.ASMB | $4.32M | 0.9% |
| Amylyx Pharmaceuticals, Inc. | $4.23M | 0.9% |
| Arcus Biosciences, Inc. | $4.05M | 0.9% |
| Perspective Therapeutics, Inc. | $3.12M | 0.7% |
| Harrow, Inc. | $344.5K | 0.1% |